The Egyptian Journal of Hospital Medicine
Prior to the availability of enzyme-replacement therapy, individuals with LAL-D were treated with lipid lowering medication, liver transplant, and stem cell transplant, none of which corrected the multisystem nature of the disorder
A licensed provider should review your health history, medications, symptoms, and goals before recommending a plan
Cumulative incidence: Time to First Occurrence of MACE in FLOW Trial Cumulative incidence estimates are based on time from randomization to first EAC-confirmed MACE with non-CV death modelled as competing risk
Zie ook: Citrulline BCAA's - werken ze of niet
The physician should list previous and current therapies for the diagnosis, including drug names, start/end dates, outcomes (intolerance/adverse event or inadequate response), and whether each medication will be continued with the new therapy